Xiaolin Wang

Insider Reports History

Location
Redwood City, CA
Signature
/s/ Jack Anders, as Attorney-in-fact for Xiaolin Wang
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Xiaolin Wang:

Company Role Class Num Shares Value Price $ Report Date Ownership
Revolution Medicines, Inc. EVP, Clinical Development Common Stock 102,321 $4,144,001 $40.50 17 Mar 2025 Direct
Revolution Medicines, Inc. EVP, Clinical Development Stock Option (Right to Buy) 66,500 01 Mar 2025 Direct

Insider Reports Filed by Xiaolin Wang

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RVMD Revolution Medicines, Inc. 17 Mar 2025 1 $0 4 EVP, Clinical Development 19 Mar 2025, 17:40
RVMD Revolution Medicines, Inc. 01 Mar 2025 2 $0 4 Officer 04 Mar 2025, 19:01
RVMD Revolution Medicines, Inc. 01 Mar 2024 2 $0 4 Officer 05 Mar 2024, 16:52
RVMD Revolution Medicines, Inc. 17 Mar 2023 1 -$15,551 4 EVP, Clinical Development 21 Mar 2023, 20:32
RVMD Revolution Medicines, Inc. 01 Mar 2023 2 $0 4 EVP, Clinical Development 03 Mar 2023, 15:17
RVMD Revolution Medicines, Inc. 19 Dec 2022 1 -$16,241 4 EVP, Clinical Development 21 Dec 2022, 15:07
RVMD Revolution Medicines, Inc. 19 Sep 2022 1 -$13,996 4 EVP, Clinical Development 21 Sep 2022, 16:18
RVMD Revolution Medicines, Inc. 17 Jun 2022 1 -$11,803 4 EVP, Clinical Development 22 Jun 2022, 17:03
RVMD Revolution Medicines, Inc. 17 Mar 2022 1 -$4,467 4 EVP, Clinical Development 21 Mar 2022, 20:02
RVMD Revolution Medicines, Inc. 01 Mar 2022 2 $0 4 EVP, Clinical Development 03 Mar 2022, 15:25
RVMD Revolution Medicines, Inc. 17 Dec 2021 1 -$6,273 4 EVP, Clinical Development 21 Dec 2021, 15:33
RVMD Revolution Medicines, Inc. 17 Sep 2021 1 -$7,505 4 EVP, Clinical Development 21 Sep 2021, 19:47
RVMD Revolution Medicines, Inc. 17 Jun 2021 1 -$8,291 4 EVP, Clinical Development 22 Jun 2021, 17:19